Arc News

The nucleosome has long been treated as a binary regulatory switch. Nucleosome-occupied DNA is inaccessible, while nucleosome-depleted DNA is open. It's a model that has organized the chromatin field for decades and underpins the interpretation of virtually every accessibility dataset ever generated, from MNase-seq to ATAC-seq. This classical framing, however, turns out to be substantially incomplete.

The idea started during the pandemic. While learning about how viruses transferred cargo from cell to cell, Felix Horns, then a postdoc, began to wonder whether the same principle could be harnessed therapeutically. By 2023, he published a proof-of-concept study in Cell showing that cells could be engineered to package and deliver mRNA to other cells.

Inspired by advances in vision-language models and robotics, we combined ESM3 (a foundation model that understands proteins at the molecular level) with Qwen3 (a language model capable of reasoning). The result is a system that can emulate how a biologist thinks while processing biological context at scales humans can't match.

In our new work published in Nature, we discovered that the aging gastrointestinal tract produces specific molecules that blunt the activity of a key gut-brain neuronal pathway, leading to age-related cognitive decline in mice.

A naturally occurring byproduct of liver metabolism—the ketone body, β-hydroxybutyrate (BHB)—can strengthen the fitness and antitumor activity of CAR T cells. The findings, reported in the journal Cell, by Arc Institute and Stanford University scientists, together with colleagues from the University of Pennsylvania, highlight a potential new way to enhance cancer immunotherapies.